New Drugs For IBS, Hepatitis C

Research presented at Digestive Disease Week® (DDW) explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea (IBS-D) and hepatitis C. An international study holds promising results for patients suffering from IBS-D. In the phase II study, researchers found that the drug ibodutant significantly improved symptoms in more than 50 percent of the individuals treated...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Irritable-Bowel Syndrome Source Type: news